Shilpa Medicare Limited (SHILPAMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.01 Billion ≈ $21.76 Million USD) by net assets (Rs24.39 Billion ≈ $263.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SHILPAMED company net worth for the company's overall valuation and market capitalisation.
Shilpa Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Shilpa Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shilpa Medicare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shilpa Medicare Limited ranked by their cash flow conversion efficiency. Explore SHILPAMED operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EIH Limited
NSE:EIHOTEL
|
0.054x |
|
CESC Limited
NSE:CESC
|
0.120x |
|
Mobileye Global Inc. Class A Common Stock
NASDAQ:MBLY
|
0.016x |
|
Shantui Construction Machinery Co Ltd
SHE:000680
|
0.056x |
|
Bomin Electronics Co Ltd
SHG:603936
|
0.009x |
|
Bet Shemesh Engines Holdings 1997 Ltd
TA:BSEN
|
-0.021x |
|
AMP Limited
F:AMP
|
-0.012x |
|
MOBVISTA INC. DL-01
F:6MO
|
N/A |
Annual Cash Flow Conversion Efficiency for Shilpa Medicare Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Shilpa Medicare Limited from 2006 to 2025. View latest Shilpa Medicare Limited stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs23.64 Billion ≈ $255.63 Million |
Rs1.32 Billion ≈ $14.29 Million |
0.056x | -26.35% |
| 2024-03-31 | Rs18.00 Billion ≈ $194.66 Million |
Rs1.37 Billion ≈ $14.78 Million |
0.076x | -40.43% |
| 2023-03-31 | Rs17.74 Billion ≈ $191.89 Million |
Rs2.26 Billion ≈ $24.46 Million |
0.127x | +119.59% |
| 2022-03-31 | Rs18.11 Billion ≈ $195.87 Million |
Rs1.05 Billion ≈ $11.37 Million |
0.058x | +81.52% |
| 2021-03-31 | Rs14.67 Billion ≈ $158.70 Million |
Rs469.28 Million ≈ $5.08 Million |
0.032x | -65.85% |
| 2020-03-31 | Rs13.21 Billion ≈ $142.91 Million |
Rs1.24 Billion ≈ $13.38 Million |
0.094x | -24.09% |
| 2019-03-31 | Rs11.90 Billion ≈ $128.69 Million |
Rs1.47 Billion ≈ $15.87 Million |
0.123x | +196.51% |
| 2018-03-31 | Rs10.80 Billion ≈ $116.78 Million |
Rs449.20 Million ≈ $4.86 Million |
0.042x | +1.43% |
| 2017-03-31 | Rs9.14 Billion ≈ $98.83 Million |
Rs374.77 Million ≈ $4.05 Million |
0.041x | -77.31% |
| 2016-03-31 | Rs7.12 Billion ≈ $77.01 Million |
Rs1.29 Billion ≈ $13.92 Million |
0.181x | +47.44% |
| 2015-03-31 | Rs5.61 Billion ≈ $60.71 Million |
Rs688.06 Million ≈ $7.44 Million |
0.123x | -28.87% |
| 2014-03-31 | Rs4.06 Billion ≈ $43.96 Million |
Rs700.41 Million ≈ $7.57 Million |
0.172x | +29.97% |
| 2013-03-31 | Rs3.29 Billion ≈ $35.60 Million |
Rs436.38 Million ≈ $4.72 Million |
0.133x | -30.71% |
| 2012-03-31 | Rs2.81 Billion ≈ $30.37 Million |
Rs537.36 Million ≈ $5.81 Million |
0.191x | +5.31% |
| 2011-03-31 | Rs2.35 Billion ≈ $25.36 Million |
Rs426.13 Million ≈ $4.61 Million |
0.182x | -65.62% |
| 2010-03-31 | Rs1.01 Billion ≈ $10.95 Million |
Rs535.22 Million ≈ $5.79 Million |
0.528x | +4.69% |
| 2009-03-31 | Rs589.21 Million ≈ $6.37 Million |
Rs297.43 Million ≈ $3.22 Million |
0.505x | +307.88% |
| 2008-03-31 | Rs560.02 Million ≈ $6.06 Million |
Rs69.31 Million ≈ $749.54K |
0.124x | -39.79% |
| 2007-03-31 | Rs418.09 Million ≈ $4.52 Million |
Rs85.93 Million ≈ $929.33K |
0.206x | +203.23% |
| 2006-03-31 | Rs350.17 Million ≈ $3.79 Million |
Rs-69.72 Million ≈ $-753.98K |
-0.199x | -- |
About Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more